In contrast to these studies, which identified lesions or gene expression states potentially sensitizing AML cells to atRA, the AML associated transcription factor fusion protein AML1-ETO was reported to confer atRA resistance [94]. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.